The dual GLP-1-glucagon agonist pemvidutide in MASH: a phase 2b trial
Lancet
.
2025 Dec 6;406(10520):2604-2606.
doi: 10.1016/S0140-6736(25)02304-9.
Author
Frank Tacke
1
Affiliation
1
Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, 13353 Berlin, Germany. Electronic address: frank.tacke@charite.de.
PMID:
41352959
DOI:
10.1016/S0140-6736(25)02304-9
No abstract available